A detailed history of Dean Capital Management transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Dean Capital Management holds 14,018 shares of JAZZ stock, worth $1.72 Million. This represents 0.67% of its overall portfolio holdings.

Number of Shares
14,018
Holding current value
$1.72 Million
% of portfolio
0.67%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$100.57 - $116.37 $1.41 Million - $1.63 Million
14,018 New
14,018 $1.56 Million
Q4 2023

Feb 14, 2024

BUY
$114.26 - $136.0 $220,293 - $262,208
1,928 Added 19.36%
11,889 $1.46 Million
Q3 2023

Nov 14, 2023

BUY
$122.0 - $145.31 $1.22 Million - $1.45 Million
9,961 New
9,961 $1.29 Million

Others Institutions Holding JAZZ

About Jazz Pharmaceuticals plc


  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $7.71B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track Dean Capital Management Portfolio

Follow Dean Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dean Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Dean Capital Management with notifications on news.